| 000 | 01259 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517070122.0 | ||
| 264 | 0 | _c20160425 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2015.10.138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHariri, Susan | |
| 245 | 0 | 0 |
_aResponse to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States. _h[electronic resource] |
| 260 |
_bVaccine _cJan 2016 |
||
| 300 |
_a201 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAdenocarcinoma in Situ _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman papillomavirus 16 _xisolation & purification |
| 650 | 0 | 4 |
_aHuman papillomavirus 18 _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aUterine Cervical Diseases _xprevention & control |
| 650 | 0 | 4 |
_aUterine Cervical Dysplasia _xprevention & control |
| 700 | 1 | _aMarkowitz, Lauri E | |
| 700 | 1 | _aUnger, Elizabeth R | |
| 773 | 0 |
_tVaccine _gvol. 34 _gno. 2 _gp. 201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2015.10.138 _zAvailable from publisher's website |
| 999 |
_c25530988 _d25530988 |
||